Publication | Closed Access
P104 Continuing benefit of zoledronic acid for the prevention of skeletal complications in breast cancer patients with bone metastases
10
Citations
0
References
2005
Year
Bone DiseaseZoledronic AcidP104 Continuing BenefitOncologyBone HealthBreast OncologyBreast Cancer PatientsBreast CancerOsteoporosisMedicineOrthopaedic SurgeryBone Metabolism
No additional data available for this publication yet. Check back later!